NovaBridge Biosciences (NBP) Global Controller files initial Form 3 insider report

Rhea-AI Filing Summary

NovaBridge Biosciences executive Zhang Adeline Yi, who serves as Global Controller, has filed an initial insider ownership report on Form 3 for the company. The filing does not list any buy, sell, or derivative transactions and shows no reported gifts, tax withholdings, or restructurings.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Zhang Adeline Yi

(Last) (First) (Middle)

C/O NOVABRIDGE BIOSCIENCES,

2440 RESEARCH BOULEVARD, SUITE 400

(Street)

ROCKVILLE MARYLAND 20850

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
NovaBridge Biosciences [ NBP ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Global Controller

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Ex. 24.1 - Power of Attorney

No securities are beneficially owned.

	/s/ Xi-Yong (Sean) Fu as attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the NovaBridge Biosciences (NBP) Form 3 for Zhang Adeline Yi show?

The Form 3 shows that Global Controller Zhang Adeline Yi is an insider of NovaBridge Biosciences. It reports no purchases, sales, derivative exercises, gifts, tax withholdings, or restructurings in the data provided.

Are there any stock purchases or sales in the NovaBridge Biosciences (NBP) Form 3?

No, the Form 3 for NovaBridge Biosciences Global Controller Zhang Adeline Yi reports zero buy and sell transactions. The transaction summary shows no activity across purchases, sales, exercises, gifts, or restructurings.

Does the NovaBridge Biosciences (NBP) Form 3 include derivative security activity?

No, the Form 3 derivative summary is empty for Zhang Adeline Yi. The transaction summary indicates no derivative transactions, exercises, or related restructurings reported for NovaBridge Biosciences in this filing.

What insider role does Zhang Adeline Yi hold at NovaBridge Biosciences (NBP)?

Zhang Adeline Yi is identified as an officer of NovaBridge Biosciences with the title Global Controller. This position qualifies her as a reporting insider required to file ownership reports such as Form 3.

Does the NovaBridge Biosciences (NBP) Form 3 indicate any gifts or tax-related share withholdings?

No, the filing shows giftCount and taxWithholdingCount as zero for Zhang Adeline Yi. This means there are no reported share gifts or tax withholding-related dispositions in this Form 3.